27 patents
Page 2 of 2
Utility
Methods for Treating Acute Myeloid Leukemia and Related Conditions
11 Mar 21
Methods for treating or inhibiting cancer and/or one or more related conditions by administering to a subject in need thereof an effective amount of a compound of Formula (I), a prodrug thereof, or a pharmaceutically acceptable salt of any of the foregoing.
Helen M. THACKRAY, Henry H. FLANNER, Curt D. WOLFGANG
Filed: 4 Mar 19
Utility
E-selectin Antagonist Compounds, Compositions, and Methods of Use
21 Jan 21
Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand.
John L. MAGNANI, Arun K. SARKAR, Myung-Gi BAEK, Frank E. ANDERSON, III, Yanhong LI
Filed: 17 Aug 20
Utility
Heterobifunctional Inhibitors of E-selectin and GALECTIN-3
23 Dec 20
John L. MAGNANI, John M. PETERSON, Arun K. SARKAR, Yusufbhai U. VOHRA, Hong-Woon YANG
Filed: 27 Dec 18
Utility
Haloalkyl Fucose-containing Selectin Antagonists
7 Oct 20
Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed.
Beat ERNST, Norbert VARGA, Martin SMIESKO, Beatrice WAGNER, John M. PETERSON, John L. MAGNANI
Filed: 21 May 17
Utility
CorrectedHeterobifunctional Pan-Selectin Antagonists Having a Triazole Linker
3 Jun 20
Beat ERNST, Beatrice WAGNER
Filed: 29 Nov 16
Utility
E-selectin Antagonist Compounds, Compositions, and Methods of Use
20 May 20
Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand.
John L. MAGNANI, Arun K. SARKAR, Myung-Gi BAEK, Frank E. ANDERSON, III, Yanhong LI
Filed: 19 Nov 19
Utility
Galactopyranosyl-cyclohexyl Derivatives As E-selectin Antagonists
29 Apr 20
Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed.
John L MAGNANI, John M PETERSON, Arun K SARKAR, Yusufbhai U VOHRA, Myung-Gi BAEK
Filed: 11 Mar 18